const MainScrptQues = [
  {
    id: 1,
    q: "Which of the following is not considered to be an intangible asset?",
    options: [
      "A. Goods on consignment.",
      "B. Patents.",
      "C. Copyrights.",
      "D. Trademarks."
    ],
    answer: 1,
    notID: 1,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 1,
    ansExplain:
      '<div class="ExplnAns">Correct answer: A. Goods on consignment.</div>',
  },
  {
    id: 2,
    q: "A recognized intangible asset is amortized over its useful life",
    options: [
      "A. Unless the pattern of consumption of the economic benefits of the asset is not reliably determinable.",
      "B. If that life is determined to be finite.",
      "C. Unless the precise length of that life is not known.",
      "D. If that life is indefinite but not infinite."
    ],
    answer: 2,
    notID: 2,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 1,
    ansExplain:
      '<div class="ExplnAns">Correct answer: B. If that life is determined to be finite.</div>',
  },
  {
    id: 3,
    q: "Which of the following costs associated with an internally developed patent should be capitalized? ",
    options: [
      "A. Research & Development: No , Patent Registration: Yes",
      "B. Research & Development: No . Patent Registration: No",
      "C. Research & Development: Yes . Patent Registration: No",
      "D. Research & Development: Yes . Patent Registration: Yes"
    ],
    answer: 1,
    notID: 3,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 1,
    ansExplain:
      '<div class="ExplnAns">Correct answer: A</div>',
  },
  {
    id: 4,
    q: "Which of the following expenditures qualifies for asset capitalization?",
    options: [
      "A. Cost of materials used in prototype testing.",
      "B. Costs of testing a prototype and modifying its design.",
      "C. Salaries of engineering staff developing a new product.",
      "D. Legal costs associated with obtaining a patent on a new product."
    ],
    answer: 4,
    notID: 4,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 1,
    ansExplain:
      '<div class="ExplnAns">Correct answer: D. Legal costs associated with obtaining a patent on a new product.</div>',
  },
  {
    id: 5,
    q: "A purchased patent has a remaining legal life of 15 years. It should be",
    options: [
      "A. Expensed in the year of acquisition.",
      "B. Amortized over 15 years regardless of its useful life.",
      "C. Amortized over its useful life if less than 15 years.",
      "D. Amortized over 40 years."
    ],
    answer: 3,
    notID: 5,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 1,
    ansExplain:
      '<div class="ExplnAns">Correct answer: C. Amortized over its useful life if less than 15 years.</div>',
  },
  {
    id: 6,
    q: "Legal fees incurred by a company in defending its patent rights should be capitalized when the outcome of litigation is:  ",
    options: [
      "A. Successful Yes , Unsuccessful Yes",
      "B. Successful Yes , Unsuccessful No",
      "C. Successful No , Unsuccessful No",
      "D. Successful No , Unsuccessful Yes"
    ],
    answer: 2,
    notID: 6,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 1,
    ansExplain:
      '<div class="ExplnAns">Correct answer: B. Yes No</div>',
  },
  {
    id: 7,
    q: "On July 1, a company acquired a patent on its new manufacturing process, which streamlines its production operation. The cost of the patent was $17,000, and the company expects that the useful life of the new process will be 10 years, although the legal life of the patent is 17 years. The company is a calendar-year corporation and is preparing its December 31 Statement of Financial Position. At which amount should the patent be reported at December 31 of the year of acquisition?",
    options: [
      "A. $15,300",
      "B. $16,000",
      "C. $16,150",
      "D. $16,500"
    ],
    answer: 3,
    notID: 7,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 1,
    ansExplain:
      '<div class="ExplnAns">Correct answer: C. $16,150</div>',
  },
  {
    id: 8,
    q: "During the year just ended, a company incurred research and development costs of $136,000 in its laboratories relating to a patent that was granted on July 1. Costs of registering the patent equaled $34,000. The patent’s legal life is 20 years, and its estimated economic life is 10 years. In its December 31 balance sheet, what amount should the company report for the patent, net of accumulated amortization?",
    options: [
      "A. $32,300",
      "B. $33,150",
      "C. $161,500",
      "D. $165,000"
    ],
    answer: 1,
    notID: 8,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 1,
    ansExplain:
      '<div class="ExplnAns">Correct answer: A</div>',
  },
  {
    id: 9,
    q: "A corporation purchased a patent at the beginning of Year 1 for $22,100 that was to be amortized over 17 years. On July 1 of Year 8, the corporation incurred legal costs of $11,400 to successfully defend the patent. The amount of amortization expense that the corporation should record for Year 8 is",
    options: [
      "A. $2,500",
      "B. $1,971",
      "C. $1,900",
      "D. $1,300"
    ],
    answer: 3,
    notID: 9,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 1,
    ansExplain:
      '<div class="ExplnAns">Correct answer: C</div>',
  },
  {
    id: 10,
    q: "Gray Co. was granted a patent on January 2, Year 5, and appropriately capitalized $45,000 of related costs. Gray was amortizing the patent over its estimated useful life of 15 years. During Year 8, Gray paid $15,000 in legal costs in successfully defending an attempted infringement of the patent. After the legal action was completed, Gray sold the patent to the plaintiff for $75,000. Gray’s policy is to take no amortization in the year of disposal. In its Year 8 income statement, what amount should Gray report as gain from sale of patent?",
    options: [
      "A. $15,000",
      "B. $24,000",
      "C. $27,000",
      "D. $39,000"
    ],
    answer: 2,
    notID: 10,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 1,
    ansExplain:
      '<div class="ExplnAns">Correct answer: B</div>',
  },
  {
    id: 11,
    q: "Which of the following assets, if any, acquired this year in an exchange transaction is(are) potentially amortizable for public companies?",
    options: [
      "A. Goodwill No , Trademarks No",
      "B. Goodwill No , Trademarks Yes",
      "C. Goodwill Yes , Trademarks Yes",
      "D. Goodwill Yes , Trademarks No"
    ],
    answer: 2,
    notID: 11,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 1,
    ansExplain:
      '<div class="ExplnAns">Correct answer: B</div>',
  },
  {
    id: 12,
    q: "Goodwill should be tested for value impairment at which of the following levels?",
    options: [
      "A. Each identifiable long-term asset.",
      "B. Each reporting unit.",
      "C. Each acquisition unit.",
      "D. Entire business as a whole."
    ],
    answer: 2,
    notID: 12,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 1,
    ansExplain:
      '<div class="ExplnAns">Correct answer: B. Each reporting unit.</div>',
  },
  {
    id: 13,
    q: "A company should recognize goodwill in its balance sheet at which of the following points?",
    options: [
      "A. Costs have been incurred in the development of goodwill.",
      "B. Goodwill has been created in the purchase of a business.",
      "C. The company expects a future benefit from the creation of goodwill.",
      "D. The fair market value of the company’s assets exceeds the book value of the company’s assets."
    ],
    answer: 2,
    notID: 13,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 1,
    ansExplain:
      '<div class="ExplnAns">Correct answer: B. Goodwill has been created in the purchase of a business.</div>',
  },
  {
    id: 14,
    q: "Under IFRS, an entity that acquires an intangible asset may use the revaluation model for subsequent measurement only if",
    options: [
      "A. The useful life of the intangible asset can be reliably determined.",
      "B. An active market exists for the intangible asset.",
      "C. The cost of the intangible asset can be measured reliably.",
      "D. The intangible asset is a monetary asset."
    ],
    answer: 2,
    notID: 14,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 1,
    ansExplain:
      '<div class="ExplnAns">Correct answer: B </div>',
  },
  {
    id: 15,
    q: "Which one of the following statements is correct about the reconciliation of U.S. GAAP and International Financial Reporting Standards (IFRS)?",
    options: [
      "A. The costs of development generally are expensed under U.S. GAAP, but are capitalized under IFRS if they meet specific criteria.",
      "B. The costs of research must be expensed under U.S. GAAP, but are capitalized under IFRS if they meet specific criteria.",
      "C. All costs of research and development must be expensed under both U.S. GAAP and IFRS.",
      "D. Internally generated goodwill may not be capitalized under U.S. GAAP, but it may be capitalized under IFRS."
    ],
    answer: 1,
    notID: 15,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 1,
    ansExplain:
      '<div class="ExplnAns">Correct answer: A. The costs of development generally are expensed under U.S. GAAP, but are capitalized under IFRS if they meet specific criteria.</div>',
  },
  {
    id: 16,
    q: "How does IFRS differ from U.S. GAAP with respect to accounting for development costs?",
    options: [
      "A. U.S. GAAP does not allow capitalization of development costs, even after technically feasible, whereas IFRS does.",
      "B. U.S. GAAP requires capitalization of development costs, whereas IFRS makes capitalization of these costs optional.",
      "C. U.S. GAAP treats development costs as part of goodwill, whereas IFRS treats these costs as an intangible asset.",
      "D. U.S. GAAP requires expensing of all development costs and IFRS requires capitalizing all development costs."
    ],
    answer: 1,
    notID: 16,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 2,
    ansExplain:
      '<div class="ExplnAns">Correct answer: A</div>',
  },
  {
    id: 17,
    q: "Which one of the following statements correctly describes the accounting treatment of research and development costs (R&D) under U.S. GAAP and IFRS?",
    options: [
      "A. Both U.S. GAAP and IFRS allow for costs of R&D to be capitalized.",
      "B. Neither U.S. GAAP nor IFRS allow for costs of R&D to be capitalized.",
      "C. U.S. GAAP allow for the capitalization of the costs of R&D, and IFRS require R&D costs to be expensed.",
      "D. U.S. GAAP require R&D to be expensed, and IFRS require research costs to be expensed but allow for the capitalization of the development costs."
    ],
    answer: 4,
    notID: 17,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 2,
    ansExplain:
      '<div class="ExplnAns">Correct answer: D. U.S. GAAP require R&D to be expensed, and IFRS require research costs to be expensed but allow for the capitalization of the development costs.</div>',
  },
  {
    id: 18,
    q: "A liability arising from a loss contingency should be recorded if the",
    options: [
      "A. Amount of the loss can be reasonably estimated.",
      "B. Contingent future events have a reasonably possible chance of occurring.",
      "C. Contingent future events have a reasonably possible chance of occurring and the amount of the loss can be reasonably estimated.",
      "D. Contingent future events will probably occur, and the amount of the loss can be reasonably estimated."
    ],
    answer: 4,
    notID: 18,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 2,
    ansExplain:
      '<div class="ExplnAns">Correct answer: D. Contingent future events will probably occur, and the amount of the loss can be reasonably estimated.</div>',
  },
  {
    id: 19,
    q: "Linden Corporation is a defendant in a lawsuit where the plaintiff is seeking $1,000,000 in damages. The company had terminated the plaintiff, George Russell, from his position with Linden after Russell allegedly sold specifications for one of Linden’s new products to a competitor. Linden’s attorney believes that it is quite possible Linden will lose the case and that, if so, damages could range from $100,000 to $200,000. Regardless of the outcome of the case, Linden’s accountants estimate the company will incur an additional $5,000 in unemployment costs because of Russell’s termination. The amount that Linden should accrue because of the contingency in this situation is",
    options: [
      "A. $200,000",
      "B. $100,000",
      "C. $5,000",
      "D. $0"
    ],
    answer: 4,
    notID: 19,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 2,
    ansExplain:
      '<div class="ExplnAns">Correct answer: D </div>',
  },
  {
    id: 20,
    q: "A company is the plaintiff in two lawsuits. The first suit involves a competitor who has made an exact copy of one of the company’s products, and the company is suing for patent infringement. The attorneys estimate a $5,000,000 award for the company; however, it is anticipated that the case will be in litigation for 2 to 3 years before final resolution. The second case also involves patent infringement; however, in this instance, the attorneys do not believe the company has a strong case. It is estimated that the company has a 50% chance of winning and the award, if any, would be in the $250,000 to $1,000,000 range. The most appropriate amount to be recorded as a gain contingency is",
    options: [
      "A. $0",
      "B. $5,000,000",
      "C. $5,125,000",
      "D. $5,250,000"
    ],
    answer: 1,
    notID: 20,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 2,
    ansExplain:
      '<div class="ExplnAns">Correct answer: A. $0</div>',
  },
  {
    id: 21,
    q: "A company is being sued in a wrongful discharge suit for $500,000. The company attorney has advised that the probability of the plaintiff prevailing and receiving the full amount is about 80%. The attorney also indicated that the case would likely be tied up in the courts for 2 to 3 years. The most appropriate financial statement presentation for this loss contingency would be to",
    options: [
      "A. Record $500,000 as a loss contingency.",
      "B. Record $400,000 as a loss contingency.",
      "C. Disclose the loss contingency in the footnotes.",
      "D. Not record or footnote the loss contingency."
    ],
    answer: 1,
    notID: 21,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 2,
    ansExplain:
      '<div class="ExplnAns">Correct answer: A.</div>',
  },
  {
    id: 22,
    q: "In May Year 1, Caso Co. filed suit against Wayne, Inc., seeking $1.9 million in damages for patent infringement. A court verdict in November Year 4 awarded Caso $1.5 million in damages, but Wayne’s appeal is not expected to be decided before Year 6. Caso’s counsel believes it is probable that Caso will be successful against Wayne for an estimated amount in the range between $800,000 and $1.1 million, with $1 million considered the most likely amount. What amount should Caso record as income from the lawsuit in the year ended December 31, Year 4?",
    options: [
      "A. $0",
      "B. $800,000",
      "C. $1,000,000",
      "D. $1,500,000"
    ],
    answer: 1,
    notID: 22,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 2,
    ansExplain:
      '<div class="ExplnAns">Correct answer: A. $0</div>',
  },
  {
    id: 23,
    q: "A corporation entered into a purchase commitment to buy inventory. At the end of the accounting period, the current market value of the inventory was less than the fixed purchase price by a material amount. Which of the following accounting treatments is most appropriate?",
    options: [
      "A. Describe the nature of the contract in a note to the financial statements, recognize a loss in the income statement, and recognize a liability for the accrued loss.",
      "B. Describe the nature of the contract and the estimated amount of the loss in a note to the financial statements, but do not recognize a loss in the income statement.",
      "C. Describe the nature of the contract in a note to the financial statements, recognize a loss in the income statement, and recognize a reduction in inventory equal to the amount of the loss by use of a valuation account.",
      "D. Neither describe the purchase obligation nor recognize a loss on the income statement or balance sheet."
    ],
    answer: 1,
    notID: 23,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 2,
    ansExplain:
      '<div class="ExplnAns">Correct answer: A. Describe the nature of the contract in a note to the financial statements, recognize a loss in the income statement, and recognize a liability for the accrued loss.</div>',
  },
  {
    id: 24,
    q: "Net losses on firm purchase commitments to acquire goods for inventory result from a contract price that exceeds the current market price. If a firm expects that losses will occur when the purchase occurs, expected losses, if material,",
    options: [
      "A. Should be recognized in the accounts and separately disclosed as losses on the income statement of the period during which the decline in price takes place.",
      "B. Should be recognized in the accounts and separately disclosed as net unrealized losses on the balance sheet at the end of the period during which the decline in price takes place.",
      "C. Should be recognized in the accounts and separately disclosed as net unrealized losses on the balance sheet at the end of the period during which the contract is executed.",
      "D. Should not be recognized in the accounts until the contract is executed and need not be separately disclosed in the financial statements."
    ],
    answer: 1,
    notID: 24,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 2,
    ansExplain:
      '<div class="ExplnAns">Correct answer: A. Should be recognized in the accounts and separately disclosed as losses on the income statement of the period during which the decline in price takes place.</div>',
  },
  {
    id: 25,
    q: "Which one of the following loss contingencies would be accrued as a liability rather than disclosed in the notes to the financial statement?",
    options: [
      "A. A guarantee of the indebtedness of another.",
      "B. A dispute over additional income taxes assessed for prior years (now in litigation).",
      "C. A pending lawsuit with an uncertain outcome.",
      "D. Liabilities for service or product warranties made as a regular part of business."
    ],
    answer: 4,
    notID: 25,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 2,
    ansExplain:
      '<div class="ExplnAns">Correct answer: D. Liabilities for service or product warranties made as a regular part of business.</div>',
  },
  {
    id: 26,
    q: "An entity sells appliances that include a 3-year assurance-type warranty. Service calls under the warranty are performed by an independent mechanic under a contract with the entity. Based on experience, warranty costs are estimated at $30 for each machine sold. When should the entity recognize these warranty costs?",
    options: [
      "A. Evenly over the life of the warranty.",
      "B. When the service calls are performed.",
      "C. When payments are made to the mechanic.",
      "D. When the machines are sold."
    ],
    answer: 4,
    notID: 26,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 2,
    ansExplain:
      '<div class="ExplnAns">Correct answer: D</div>',
  },
  {
    id: 27,
    q: "A company manufactures stereo systems that carry a 2-year assurance-type warranty against defects. Based on past experience, warranty costs are estimated at 4% of sales for the warranty period. During the year, stereo system sales totaled $3 million, and warranty costs of $67,500 were incurred. In its income statement for the year ended December 31, the company should report warranty expense of",
    options: [
      "A. $52,500",
      "B. $60,000",
      "C. $67,500",
      "D. $120,000"
    ],
    answer: 4,
    notID: 27,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 2,
    ansExplain:
      '<div class="ExplnAns">Correct answer: D</div>',
  },
  {
    id: 28,
    q: `During Year 3, a new product carrying a 2-year assurance-type warranty against defects was introduced. The estimated warranty costs related to dollar sales are 2% within 12 months following sale and 4% in the second 12 months following sale. Sales and actual warranty expenditures for the years ended December 31, Year 3 and Year 4, are as follows:
    <table border="1">
  <tr>
    <th>Year</th>
    <th>Sales</th>
    <th>Actual Warranty Expenditures</th>
  </tr>
  <tr>
    <td>Year 3</td>
    <td>$600,000</td>
    <td>$9,000</td>
  </tr>
  <tr>
    <td>Year 4</td>
    <td>$1,000,000</td>
    <td>$30,000</td>
  </tr>
  <tr>
    <td>Total</td>
    <td>$1,600,000</td>
    <td>$39,000</td>
  </tr>
</table>
 At December 31, Year 4, what amount of estimated warranty liability should be reported?`,
    options: [
      "A. $0",
      "B. $39,000",
      "C. $57,000",
      "D. $96,000"
    ],
    answer: 3,
    notID: 28,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 2,
    ansExplain:
      '<div class="ExplnAns">Correct answer: C</div>',
  },
  {
    id: 29,
    q: "On April 1, a corporation began offering a new product for sale under a standard 1-year assurance- type warranty. Of the 5,000 units in inventory at April 1, 3,000 had been sold by June 30. Based on its experience with similar products, the corporation estimated that the average warranty cost per unit sold would be $8. Actual warranty costs incurred from April 1 through June 30 were $7,000. At June 30, what amount should the corporation report as estimated warranty liability?",
    options: [
      "A. $9,000",
      "B. $16,000",
      "C. $17,000",
      "D. $33,000"
    ],
    answer: 3,
    notID: 29,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 2,
    ansExplain:
      '<div class="ExplnAns">Correct answer: C </div>',
  },
  {
    id: 30,
    q: "A manufacturer produced 80,000 units and sold them for $1,200 each. The company estimates that 4% of the units will have a defect which will cost an estimated $95 each to repair. During this year, the company honored $159,000 in actual assurance-type warranty costs. Using the assurance warranty approach, what would be the balance of the warranty liability account at the end of its first year of operations?",
    options: [
      "A. $463,000.",
      "B. $304,000.",
      "C. $159,000.",
      "D. $145,000."
    ],
    answer: 4,
    notID: 30,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 2,
    ansExplain:
      '<div class="ExplnAns">Correct answer: D</div>',
  },
  {
    id: 31,
    q: "When using fair value accounting, it would be to a firm's benefit to report the liability at fair value when it has",
    options: [
      "A. $28 million in outstanding bonds trading at 98%.",
      "B. $25 million in puttable bonds trading at 102%.",
      "C. $50 million in variable rate preferred shares outstanding.",
      "D. $32 million in outstanding bonds trading at 101%."
    ],
    answer: 1,
    notID: 31,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 1,
    ansExplain:
      '<div class="ExplnAns">Correct answer: A </div>',
  },
  {
    id: 32,
    q: "Costs that are capitalized with regard to a patent include",
    options: [
      "A. Incidental costs of obtaining the patent, costs of successful and unsuccessful patent infringement suits, and the value of any signed patent licensing agreement.",
      "B. Legal fees of obtaining the patent, incidental costs of obtaining the patent, and research and development costs incurred on the invention that is patented.",
      "C. Legal fees of obtaining the patent, incidental costs of obtaining the patent, and costs of successful patent infringement suits.",
      "D. Legal fees of obtaining the patent, costs of successful patent infringement suits, and research and development costs incurred on the invention that is patented."
    ],
    answer: 3,
    notID: 32,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 1,
    ansExplain:
      '<div class="ExplnAns">Correct answer: C </div>',
  },
  {
    id: 33,
    q: "An employee of M, a public company, developed a new product that has just been patented. The development costs of this product were negligible, but the patent rights are almost certainly worth many millions of dollars. Which accounting concept would prevent the company from recognizing the value of this patent as a non-current asset in its balance sheet?",
    options: [
      "A. Going concern",
      "B. Historical cost",
      "C. Conservatism",
      "D. Materiality"
    ],
    answer: 2,
    notID: 33,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 1,
    ansExplain:
      '<div class="ExplnAns">Correct answer: B</div>',
  },
  {
    id: 34,
    q: "According to ASC 730-10-25-2, Research and Development-Elements of Costs to Be Identified with Research and Development Activities, expenditures for equipment for research and development",
    options: [
      "A. must be expensed in the period incurred, unless the costs are for testing a prototype.",
      "B. must be capitalized in the period incurred and amortized over the estimated life of the asset.",
      "C. must be expensed in the period incurred, unless the equipment has alternative uses in other R&D projects or otherwise.",
      "D. may be expensed in the period incurred or capitalized if the probability of future benefits can readily be determined."
    ],
    answer: 3,
    notID: 34,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 1,
    ansExplain:
      '<div class="ExplnAns">Correct answer: C </div>',
  },
  {
    id: 35,
    q: "On September 1, 20X3, for $4,000,000 cash and $2,000,000 notes payable, Norbend Corporation acquired the net assets of Crisholm Company, which had a fair value of $5,496,000 on that date. During the December 31, 20X5 year-end audit after all adjusting entries have been made, the goodwill is determined to be worthless. The amount of the write-off as of December 31, 20X5 should be:",
    options: [
      "A. $474,600",
      "B. $478,800",
      "C. $466,200",
      "D. $504,000"
    ],
    answer: 4,
    notID: 35,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 1,
    ansExplain:
      '<div class="ExplnAns">Correct answer: D </div>',
  },
  {
    id: 36,
    q: "Pie Baker, Ltd. purchased a secret fruit pie recipe for $75,000. An additional $10,000 was spent in securing the secret recipe and safeguarding its contents. Pie Baker expects to keep the recipe a secret indefinitely. Because of taste changes, the industry has found that recipes have been used for an average of 8 years. Based on this information, Pie Baker should",
    options: [
      "A. Capitalize the $85,000 cost and amortize it over 8 years.",
      "B. Expense the $85,000 cost because the secret formula cost should not be capitalized.",
      "C. Capitalize the $85,000 cost and then amortize it over the period the recipe is to remain a secret.",
      "D. Capitalize the $85,000 cost and then amortize it over 40 years."
    ],
    answer: 1,
    notID: 36,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 1,
    ansExplain:
      '<div class="ExplnAns">Correct answer: A </div>',
  },
  {
    id: 37,
    q: "How does IFRS differ from U.S. GAAP with respect to accounting for development costs?",
    options: [
      "A. U.S. GAAP requires expensing of all development costs and IFRS requires capitalizing all development costs.",
      "B. U.S. GAAP treats development costs as part of goodwill, whereas IFRS treats these costs as an intangible asset.",
      "C. U.S. GAAP does not allow capitalization of development costs unless they are for materials, equipment, or facilities that have alternative future uses. IFRS allows capitalization of development costs but only if technical feasibility has been established.",
      "D. U.S. GAAP requires capitalization of development costs, whereas IFRS makes capitalization of these costs optional."
    ],
    answer: 3,
    notID: 37,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 1,
    ansExplain:
      '<div class="ExplnAns">Correct answer: C. U.S. GAAP does not allow capitalization of development costs unless they are for materials, equipment, or facilities that have alternative future uses. IFRS allows capitalization of development costs but only if technical feasibility has been established.</div>',
  },
  {
    id: 38,
    q: "The selling price of a new company's units is $10,000 each. The buyers are provided with a 2-year assurance-type warranty that is expected to cost the company $250 per unit in the year of the sale and $750 per unit in the year following the sale. The company sold 80 units in the first year of operation and 100 units in the second year. Actual payments for warranty claims were $10,000 and $65,000 in years one and two, respectively. The amount charged to assurance-type warranty expense during the second year of operation is:",
    options: [
      "A. $100,000",
      "B. $25,000",
      "C. $85,000",
      "D. $65,000"
    ],
    answer: 1,
    notID: 38,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 1,
    ansExplain:
      '<div class="ExplnAns">Correct answer: A </div>',
  },
  {
    id: 39,
    q: "Beginning January 1, Year 1, Center Company offered a 3-year assurance-type warranty from date of sale on any of its products sold after January 1, Year 1. The warranty offer was part of a program to increase sales. Meeting the terms of the warranty was expected to cost Center 4% of sales. Sales made under warranty in Year 1 totaled $9,000,000, and one-fifth of the units sold were returned. These units were repaired or replaced at a cost of $65,000. The amount of assurance-type warranty expense that should appear on Center's Year 1 income statement is",
    options: [
      "A. $72,000",
      "B. $65,000",
      "C. $360,000",
      "D. $137,000"
    ],
    answer: 3,
    notID: 39,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 1,
    ansExplain:
      '<div class="ExplnAns">Correct answer: C </div>',
  },
  {
    id: 40,
    q: `In Year 1, the Voorhees Corporation introduced a new line of computer products that carry a 2-year assurance-type warranty against defects in workmanship. The company estimates that the total warranty cost will be 10% of sales, with 40% of the expenditures occurring during the first year and 60% during the second year. Sales and actual warranty expenditures for Year 1 and Year 2 were as follows:
    <table border="1">
  <tr>
    <th>Year</th>
    <th>Actual Sales</th>
    <th>Warranty Expenditures</th>
  </tr>
  <tr>
    <td>1</td>
    <td>$300,000</td>
    <td>$12,000</td>
  </tr>
  <tr>
    <td>2</td>
    <td>$400,000</td>
    <td>$30,000</td>
  </tr>
</table>
At the end of Year 2, the balance in the assurance-type warranty liability account will be:`,
    options: [
      "A. $58,000",
      "B. $46,000",
      "C. $28,000",
      "D. $24,000"
    ],
    answer: 3,
    notID: 40,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 1,
    ansExplain:
      '<div class="ExplnAns">Correct answer: C </div>',
  },
  {
    id: 41,
    q: "Equip Corp., a manufacturer of small commercial heating units, follows the generally accepted method of accounting for assurance-type warranties in accounting for estimated future warranty costs. The company recently designed and manufactured a new model, 250 units of which were sold (with a one-year warranty) for $6,000 per unit during November of the current year. Estimated future warranty costs ($150 per unit, based on past experience) were not accounted for at the time of sale, and the company incurred no warranty cost during November and December of the current year. The year-end adjusting entry required at December 31 of the current year to account for estimated future warranty costs would be to",
    options: [
      "A. Dr. sales for $37,500 and Cr. contract liabilities for $37,500.",
      "B. Dr. contract liabilities and Cr. cash or accounts receivable for $37,500.",
      "C. Dr. sales for $37,500 and Cr. assurance-type warranty liability for $37,500.",
      "D. Dr. assurance - warranty ex. for $37,500 and Cr. assurance - warranty liability For $37,500."
    ],
    answer: 4,
    notID: 41,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 1,
    ansExplain:
      '<div class="ExplnAns">Correct answer: D </div>',
  },
  {
    id: 42,
    q: "A company is subject to assurance-type warranty claims. It is estimated that between $1,000,000 and $3,000,000 will probably be paid out. No estimate of loss within this range is a better estimate than any other amount. The company should:",
    options: [
      "A. Defer a loss of $1,000,000 to $3,000,000.",
      "B. Accrue a loss of $1,000,000.",
      "C. Make no journal entry at this time.",
      "D. Disclose only a possible loss."
    ],
    answer: 2,
    notID: 42,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 1,
    ansExplain:
      '<div class="ExplnAns">Correct answer: B </div>',
  },
  {
    id: 43,
    q: "Trade accounts payable are valued on the statement of financial position at the",
    options: [
      "A. Historical cost.",
      "B. Net settlement value.",
      "C. Current cost.",
      "D. Current market value."
    ],
    answer: 2,
    notID: 43,
    yourAns: "",
    yourNote: "",
    yourChck: "",
    id2: 1,
    ansExplain:
      '<div class="ExplnAns">Correct answer: B </div>',
  }
];



function updateElementWithArrayCount(array) {
  var count = array.length;

  // Multiply by 2
  var result = count * 1.8; 
  if (result > 360) {
    result = 360;
  }

  var element = document.getElementById("timeinmins");

  if (element) {
    element.textContent = result;
  } else {
    console.error("Element not found");
  }
}
updateElementWithArrayCount(MainScrptQues);
